{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:38:47Z","timestamp":1792291127304,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017570","name":"Commonwealth Serum Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.cardfail.2021.07.016","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T10:59:12Z","timestamp":1628938752000},"page":"21-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4919-0146","authenticated-orcid":false,"given":"Zachary L.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie Ann","family":"Sarrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0405-7878","authenticated-orcid":false,"given":"Mary Katherine","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-8998","authenticated-orcid":false,"given":"Brent","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P.","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3940-1680","authenticated-orcid":false,"given":"Kausik","family":"Umanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-8764","authenticated-orcid":false,"given":"William","family":"Tidwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Guide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Testani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia B.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8402-8961","authenticated-orcid":false,"given":"Jamie P.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2021.07.016_bib0001","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0002","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ejhf.1578","article-title":"Acute heart failure congestion and perfusion status - impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry","volume":"21","author":"Chioncel","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0003","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","volume":"8","author":"Lala","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0004","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","article-title":"Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure","volume":"258","author":"Rubio-Gracia","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0005","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-019-09851-9","article-title":"Loop diuretic resistance complicating acute heart failure","volume":"25","author":"Cox","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0007","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0008","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0009","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0010","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC Expert Consensus Decision Pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0011","doi-asserted-by":"crossref","unstructured":"Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012;367:2296\u2013304. doi:10.1056\/NEJMoa1210357","DOI":"10.1056\/NEJMoa1210357"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jchf.2015.08.005","article-title":"Aquapheresis versus intravenous diuretics and hospitalizations for heart failure","volume":"4","author":"Costanzo","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009149","article-title":"Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: a propensity analysis","volume":"7","author":"Brisco-Bacik","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchf.2019.09.012","article-title":"Diuretic strategies for loop diuretic resistance in acute heart failure: the 3T Trial","volume":"8","author":"Cox","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCHEARTFAILURE.113.000895","article-title":"Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure","volume":"7","author":"Testani","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0016","series-title":"R: A language and environment for statistical computing","year":"2020"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0017","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1681\/ASN.2016111178","article-title":"Compensatory distal reabsorption drives diuretic resistance in human heart failure","volume":"28","author":"Rao","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0018","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ejhf.757","article-title":"Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure","volume":"19","author":"Ter Maaten","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0019","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0020","doi-asserted-by":"crossref","unstructured":"Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011;364:797\u2013805. doi:10.1056\/NEJMoa1005419","DOI":"10.1056\/NEJMoa1005419"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0021","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cardfail.2018.02.002","article-title":"Determinants of diuretic responsiveness and associated outcomes during acute heart failure hospitalization: an analysis from the NHLBI Heart Failure Network Clinical Trials","volume":"24","author":"Kiernan","year":"2018","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0022","doi-asserted-by":"crossref","unstructured":"Chen HH, Anstrom KJ, Givertz MM, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 2013;310:2533\u201343. doi:10.1001\/jama.2013.282190","DOI":"10.1001\/jama.2013.282190"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0023","article-title":"Triple diuretics and aquaretic strategy for acute decompensated heart failure due to volume overload","volume":"2013","author":"Jermyn","year":"2013","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IJNRD.S135660","article-title":"Combined aquaretic and diuretic therapy in acute heart failure","volume":"10","author":"Goyfman","year":"2017","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","article-title":"Sequential nephron blockade breaks resistance to diuretics in edematous states","volume":"29","author":"Knauf","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0026","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/AC.70.3.3080630","article-title":"Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload","volume":"70","author":"Verbrugge","year":"2015","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0027","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance","volume":"21","author":"Verbrugge","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0028","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jacc.2020.12.022","article-title":"Natriuretic equation to predict loop diuretic response in patients with heart failure","volume":"77","author":"Rao","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0029","doi-asserted-by":"crossref","unstructured":"Bansal S, Lindenfeld J, Schrier RW. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2009;2:370\u20136. doi:10.1161\/CIRCHEARTFAILURE.108.821199","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0030","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jchf.2016.06.003","article-title":"Rationale and design of the ATHENA-HF trial: aldosterone targeted neurohormonal combined with natriuresis therapy in heart failure","volume":"4","author":"Butler","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0031","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and Safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0032","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ejhf.1802","article-title":"Spironolactone metabolite concentrations in decompensated heart failure: insights from the ATHENA-HF trial","volume":"22","author":"de Denus","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0033","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2012.08.957","article-title":"Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure","volume":"60","author":"Patarroyo","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0034","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.cardfail.2016.01.007","article-title":"Serum bicarbonate in acute heart failure: relationship to treatment strategies and clinical outcomes","volume":"22","author":"Cooper","year":"2016","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0035","first-page":"1527","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0036","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jacc.2013.05.020","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0037","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1161\/HYPERTENSIONAHA.115.05838","article-title":"Urinary proteolytic activation of renal epithelial NA+ channels in chronic heart failure","volume":"67","author":"Zheng","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0038","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MNH.0b013e32821f6072","article-title":"Role of proteolysis in the activation of epithelial sodium channels","volume":"16","author":"Hughey","year":"2007","journal-title":"Curr Opinion Nephrol Hypertens"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0039","doi-asserted-by":"crossref","first-page":"F641","DOI":"10.1152\/ajprenal.00254.2010","article-title":"Increased renal ENaC subunits and sodium retention in rats with chronic heart failure","volume":"300","author":"Zheng","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchf.2019.10.008","article-title":"Is resistance futile? Addressing diuretic resistance during hospitalization for heart failure","volume":"8","author":"Loungani","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0041","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","article-title":"Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure","volume":"69","author":"Felker","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0042","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","article-title":"Empagliflozin in heart failure: diuretic and cardio-renal effects","volume":"142","author":"Griffin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2021.07.016_bib0043","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191642100333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191642100333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:46:03Z","timestamp":1761029163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191642100333X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S107191642100333X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.016","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2021.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}